ConductScience.org, home

Paper20058049

Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery.

Mitsuya K and 9 others. J Neurooncol, 2010. Cited by 150 papers, by iCite.

Cite this record

ConductScience Library. Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery. Papers, record 20058049. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20058049

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery.
PubMed
Journal
J Neurooncol
PubMed
Year
2010
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
150
iCite
Relative citation ratio, by iCite
4.76
iCite
Revised in PubMed
2022-03-21
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mitsuya KKoichi
2Nakasu YYoko
3Horiguchi SSatoshi
4Harada HHideyuki
5Nishimura TTetsuo
6Bando EEtsuro
7Okawa HHiroto
8Furukawa YYoshihiro
9Hirai TTatsuo
10Endo MMasahiro

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Brain NeoplasmsMajor topic
Magnetic Resonance AngiographyMajor topic
Neoplasm Recurrence, LocalMajor topic
Radiation InjuriesMajor topic
RadiosurgeryMajor topic
Adult
Aged
Aged, 80 and over
Cerebrovascular Circulation
Contrast Media
Female
Humans
Male
Middle Aged
Prospective Studies
Retrospective Studies
Sensitivity and Specificity

Source PubMed

Download CSV of topics

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115087722Assessment of irradiated brain metastases by means of arterial spin-labeling and dynamic susceptibility-weighted contrast-enhanced perfusion MRI: initial results.Invest Radiol2004https://conductscience.org/library/papers/15087722PubMed
210318717Clinical applications of intracranial perfusion MR imaging.Neuroimaging Clin N Am1999https://conductscience.org/library/papers/10318717PubMed
315158627Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.Lancet2004https://conductscience.org/library/papers/15158627PubMed
48699239Association of rubidium and C-methionine uptake in brain tumors measured by positron emission tomography.J Neurooncol1996https://conductscience.org/library/papers/8699239PubMed
516937146Comparison of cerebral blood volume and permeability in preoperative grading of intracranial glioma using CT perfusion imaging.Neuroradiology2006https://conductscience.org/library/papers/16937146PubMed
67526239Effect of radiosurgery using Leksell gamma unit on metastatic brain tumor--autopsy case report.Neurol Med Chir (Tokyo)1994https://conductscience.org/library/papers/7526239PubMed
711079496PET in differentiation of recurrent brain tumor from radiation injury.J Nucl Med2000https://conductscience.org/library/papers/11079496PubMed
817986939First-pass perfusion computed tomography: initial experience in differentiating recurrent brain tumors from radiation effects and radiation necrosis.Neurosurgery2007https://conductscience.org/library/papers/17986939PubMed
915502131Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis.AJNR Am J Neuroradiol2004https://conductscience.org/library/papers/15502131PubMed
102345506Perfusion imaging with NMR contrast agents.Magn Reson Med1990https://conductscience.org/library/papers/2345506PubMed
1111856703Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging.AJR Am J Roentgenol2002https://conductscience.org/library/papers/11856703PubMed
1217886561Prediction of oligodendroglial tumor subtype and grade using perfusion weighted magnetic resonance imaging.J Neurosurg2007https://conductscience.org/library/papers/17886561PubMed
1314585263The management of brain metastases.Cancer Treat Rev2003https://conductscience.org/library/papers/14585263PubMed
1416172969Differentiation of the radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases: importance of multi-voxel proton MRS.Minim Invasive Neurosurg2005https://conductscience.org/library/papers/16172969PubMed
1516611778Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma?AJNR Am J Neuroradiol2006https://conductscience.org/library/papers/16611778PubMed
168134596Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings.Radiology1994https://conductscience.org/library/papers/8134596PubMed
1718413375Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy.J Nucl Med2008https://conductscience.org/library/papers/18413375PubMed
1810815666Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue.AJNR Am J Neuroradiol2000https://conductscience.org/library/papers/10815666PubMed
1912744366Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible?J Neurosurg2003https://conductscience.org/library/papers/12744366PubMed
2012461273In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience.Radiology2002https://conductscience.org/library/papers/12461273PubMed

See all 31 referencesDownload CSV of references

Cited by101

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 150 citations.

PMIDTitleJournalYearIn PapersSource
42938876
Qualitative Dynamic Contrast-Enhanced MRI Time-Intensity Curve Analysis for Differentiating Non-Progressive Treatment-Related Changes from Tumor Progression After Stereotactic Radiotherapy for Brain Metastases.
Cancers (Basel)2026https://conductscience.org/library/papers/42938876PubMed
42926244MRI of brain metastases in the era of immunotherapy, targeted agents, and artificial intelligence: from detection to treatment response assessment.MAGMA2026https://conductscience.org/library/papers/42926244PubMed
42774457Diagnostic imaging and emerging image-guided neurointervention in brain tumors: a narrative review.Front Radiol2026https://conductscience.org/library/papers/42774457PubMed
42663779Pathology-validated structural and physiologic habitat imaging for differentiating radiation necrosis from tumor recurrence in brain metastases.J Neurooncol2026https://conductscience.org/library/papers/42663779PubMed
42571295A clinical decision-support framework to differentiate radiation necrosis from tumor progression in brain metastases.Neurooncol Adv2026https://conductscience.org/library/papers/42571295PubMed
42543812Descriptive Analysis of Surgically Resected Pure Radiation Necrosis After Radiation Therapy for Brain Metastasis: Clinical Features, MRI Findings, and Outcomes.Brain Tumor Res Treat2026https://conductscience.org/library/papers/42543812PubMed
42484747The threefold value of surgery in previously irradiated brain metastases.J Neurooncol2026https://conductscience.org/library/papers/42484747PubMed
42166098
Percentage signal recovery plus relative cerebral blood volume: a practical dual-parameter strategy for differentiating post-stereotactic radiosurgery tumour progression from radiation necrosis in brain metastases.
Insights Imaging2026https://conductscience.org/library/papers/42166098PubMed
42073362
A Challenging Differential Diagnosis Between Brain Radionecrosis and Recurrent Metastatic Disease, with Temporary Clinical/Radiological Response to Bevacizumab and Later Imaging Suspicious for Oligoprogression.
Life (Basel)2026https://conductscience.org/library/papers/42073362PubMed
41451222
MRI features and preliminary diagnostic assessment using large language models of cystic tumor progression mimicking radiation necrosis in brain metastasis patients treated with immunotherapy: case report.
Front Immunol2025https://conductscience.org/library/papers/41451222PubMed
41160301Percentage of signal recovery (PSR): a more accurate marker than rCBV for differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiosurgery.J Neurooncol2025https://conductscience.org/library/papers/41160301PubMed
41036533Cerebral radiation necrosis successfully treated with high-dose bevacizumab.Respir Med Case Rep2025https://conductscience.org/library/papers/41036533PubMed
41030686Predicting Radionecrosis After Stereotactic Radiation Therapy for Solitary Brain Metastases: External Validation of a Univariable Model and Development of a Multivariable Model.Adv Radiat Oncol2025https://conductscience.org/library/papers/41030686PubMed
40913628FLAIR extending beyond a quadrant (FEQ) of the cerebrum as a qualitative imaging biomarker: a conceptual proposition and proof-of-principle.Clin Exp Metastasis2025https://conductscience.org/library/papers/40913628PubMed
40805286Auxiliary Value of [18F]F-Fluorocholine PET/CT in Evaluating Post-Stereotactic Radiosurgery Recurrence of Lung Cancer Brain Metastases: A Comparative Analysis with Contrast-Enhanced MRI.Cancers (Basel)2025https://conductscience.org/library/papers/40805286PubMed
40408063Predictive value of early DCE and DSC perfusion MRI parameters for midterm clinical outcomes in lung cancer brain metastases treated with stereotactic radiosurgery.J Neurooncol2025https://conductscience.org/library/papers/40408063PubMed
40360909Development of a recursive partitioning analysis for prediction of radiation necrosis following single-fraction stereotactic radiosurgery for intact brain metastases.J Neurooncol2025https://conductscience.org/library/papers/40360909PubMed
40217619A Practical, Short, [18F]F-DOPA PET/CT Acquisition Method for Distinguishing Recurrent Brain Metastases from Radionecrosis Following Radiotherapy.J Clin Med2025https://conductscience.org/library/papers/40217619PubMed
40172476AI differentiates radionecrosis from true progression in brain metastasis upon stereotactic radiosurgery: Analysis of 124 histologically assessed lesions.Neuro Oncol2025https://conductscience.org/library/papers/40172476PubMed
40057844Differentiation Between Radiation Necrosis and True Tumour Progression After Radiotherapy to Intracranial Metastases.J Med Imaging Radiat Oncol2025https://conductscience.org/library/papers/40057844PubMed

See all 101 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20058049

GET https://conductscience.org/api/papers/v1/20058049/references?page=2